nach oben

Erschienen in:

08.06.2017 | Original Article

Perioperative allogenic blood transfusion is a poor prognostic factor after hepatocellular carcinoma surgery: a multi-center analysis

verfasst von: Hiroshi Wada, Hidetoshi Eguchi, Hiroaki Nagano, Shoji Kubo, Takuya Nakai, Masaki Kaibori, Michihiro Hayashi, Shigekazu Takemura, Shogo Tanaka, Yasuyuki Nakata, Kosuke Matsui, Morihiko Ishizaki, Fumitoshi Hirokawa, Koji Komeda, Kazuhisa Uchiyama, Masanori Kon, Yuichiro Doki, Masaki Mori

Erschienen in: Surgery Today | Ausgabe 1/2018

Einloggen, um Zugang zu erhalten

Abstract

Purpose

The influence of allogenic blood transfusion on the postoperative outcomes of hepatocellular carcinoma (HCC) surgery remains controversial. This study aims to clarify the clinical impacts of perioperative allogenic blood transfusion on liver resection outcome in HCC patients.

Methods

We analyzed data collected over 5 years for 642 patients who underwent hepatectomy for HCC at one of the five university hospitals. We investigated the impact of allogenic blood transfusion on postoperative outcome after surgery in all patients and in 74 matched pairs, using a propensity score.

Results

Of the 642 patients, 198 (30.8%) received perioperative allogenic blood transfusion (AT group) and 444 (69.2%) did not (non-AT group). Overall survival was lower in the AT group than in the non-AT group in univariate (P < 0.001) and multivariate analyses (risk ratio 1.521, P = 0.011). After matching the different distributions using propensity scores, perioperative blood transfusion was found to be a poor prognostic factor for HCC patients.

Conclusions

In this multi-center study, perioperative blood transfusion was an independent factor for poor prognosis after curative surgery for primary HCC in the patient group and in pairs matched by propensity scores.

Nur mit Berechtigung zugänglich

Llovet JM, Burroughs A, Bruix J. Hepatocellular carcinoma. Lancet. 2003;362:1907–17.CrossRefPubMed

Marubashi S, Dono K, Nagano H, Sugita Y, Asaoka T, Hama N, et al. Detection of AFP mRNA-expressing cells in the peripheral blood for prediction of HCC recurrence after living donor liver transplantation. Transpl Int. 2007;20:576–82.CrossRefPubMed

Wall WJ, Marotta PJ. Surgery and transplantation for hepatocellular cancer. Liver Transpl. 2000;6:S16–22.CrossRefPubMed

Hammad A, Kaido T, Ogawa K, Fujimoto Y, Uemura T, Mori A, et al. Liver transplantation for advanced hepatocellular carcinoma in patients with Child–Pugh A and B. Surg Today. 2016;46:248–54.CrossRefPubMed

Nanashima A, Nagayasu T. Development and clinical usefulness of the liver hanging maneuver in various anatomical hepatectomy procedures. Surg Today. 2016;46:398–404.CrossRefPubMed

Cescon M, Vetrone G, Grazi GL, Ramacciato G, Ercolani G, Ravaioli M, et al. Trends in perioperative outcome after hepatic resection: analysis of 1500 consecutive unselected cases over 20 years. Ann Surg. 2009;249:995–1002.CrossRefPubMed

Carlos M, Caveh M, Donat RS. Allogeneic blood transfusions: benefit, risks and clinical indications in countries with a low or high human development index. Br Med Bull. 2004;70:15–28.CrossRef

Tomimaru Y, Wada H, Marubashi S, Kobayashi S, Eguchi H, Takeda Y, et al. Fresh frozen plasma transfusion does not affect outcomes following hepatic resection for hepatocellular carcinoma. World J Gastroenterol. 2010;16:5603–10.CrossRefPubMedPubMedCentral

Jensen LS, Andersen AJ, Christiansen PM, Hokland P, Juhl CO, Madsen G, et al. Postoperative infection and natural killer cell function following blood transfusion in patients undergoing elective colorectal surgery. Br J Surg. 1992;79:513–6.CrossRefPubMed

10.

Foster RS, Costanza MC, Foster JC, Wanner MC, Foster CB. Adverse relationship between blood-transfusions and survival after colectomy for colon cancer. Cancer. 1985;55:1195–201.CrossRefPubMed

11.

Fong Y, Karpeh M, Mayer K, Brennan MF. Association of perioperative transfusions with poor outcome in resection of gastric adenocarcinoma. Am J Surg. 1994;167:256–60.CrossRefPubMed

12.

Crowe JP, Gordon NH, Fry DE, Shuck JM, Hubay CA. Breast cancer survival and perioperative blood transfusion. Surgery. 1989;106:836–41.PubMed

13.

van de Watering LM, Brand A, Houbiers JG, Klein Kranenbarg WM, Hermans J, van de Velde C. Perioperative blood transfusions, with or without allogeneic leucocytes, relate to survival, not to cancer recurrence. Br J Surg. 2001;88:267–72.CrossRefPubMed

14.

Matsumata T, Ikeda Y, Hayashi H, Kamakura T, Taketomi A, Sugimachi K. The association between transfusion and cancer-free survival after curative resection for hepatocellular carcinoma. Cancer. 1993;72:1866–71.CrossRefPubMed

15.

Yamamoto J, Kosuge T, Takayama T, Shimada K, Yamasaki S, Ozaki H, et al. Perioperative blood transfusion promotes recurrence of hepatocellular carcinoma after hepatectomy. Surgery. 1994;115:303–9.PubMed

16.

Takemura M, Osugi H, Higashino M, Takada N, Lee S, Kinoshita H. Effect of substituting allogenic blood transfusion with autologous blood transfusion on outcomes after radical esophagectomy for cancer. Ann Thorac Cardiovasc Surg. 2005;11:293–300.PubMed

17.

Kuroda S, Tashiro H, Kobayashi T, Oshita A, Amano H, Ohdan H. No impact of perioperative blood transfusion on recurrence of hepatocellular carcinoma after hepatectomy. World J Surg. 2012;36:651–8.CrossRefPubMed

18.

Kwon AH, Matsui Y, Kamiyama Y. Perioperative blood transfusion in hepatocellular carcinomas: influence of immunologic profile and recurrence free survival. Cancer. 2001;91:771–8.CrossRefPubMed

19.

Rubin DB. Estimating causal effects from large data sets using propensity scores. Ann Intern Med. 1997;127:757–63.CrossRefPubMed

20.

D’Agostino RB. Propensity score methods for bias reduction in the comparison of a treatment to a non-randomized control group. Stat Med. 1998;17:2265–81.CrossRefPubMed

21.

Katayama H, Kurokawa Y, Nakamura K, Ito H, Kanemitsu Y, Masuda N, et al. Extended Clavien–Dindo classification of surgical complications: Japan Clinical Oncology Group postoperative complications criteria. Surg Today. 2016;46:668–85.CrossRefPubMed

22.

Mizuguchi T, Kawamoto M, Meguro M, Hui TT, Hirata K. Preoperative liver function assessments to estimate the prognosis and safety of liver resections. Surg Today. 2014;44:1–10.CrossRefPubMed

23.

Liu L, Wang Z, Jiang S, Shao B, Liu J, Zhang S, et al. Perioperative allogeneic blood transfusion is associated with worse clinical outcomes for hepatocellular carcinoma: a meta-analysis. PLoS One. 2013;8:e64261.CrossRefPubMedPubMedCentral

24.

Nanashima A, Abo T, Hamasaki K, Wakata K, Kunizaki M, Tou K, et al. Predictors of intraoperative blood loss in patients undergoing hepatectomy. Surg Today. 2013;43:485–93.CrossRefPubMed

25.

Sugita S, Sasaki A, Iwaki K, Uchida H, Kai S, Shibata K, et al. Prognosis and postoperative lymphocyte count in patients with hepatocellular carcinoma who received intraoperative allogenic blood transfusion: a retrospective study. Eur J Surg Oncol. 2008;34:339–45.CrossRefPubMed

26.

Yamamoto J, Kosuge T, Saiura A, Sakamoto Y, Shimada K, Sano T, et al. Effectiveness of hepatic resection for early-stage hepatocellular carcinoma in cirrhotic patients: subgroup analysis according to Milan criteria. Jpn J Clin Oncol. 2007;37:287–95.CrossRefPubMed

27.

Asahara T, Katayama K, Itamoto T, Yano M, Hino H, Okamoto Y, et al. Perioperative blood transfusion as a prognostic indicator in patients with hepatocellular carcinoma. World J Surg. 1999;23:676–80.CrossRefPubMed

28.

Tomimaru Y, Eguchi H, Marubashi S, Wada H, Kobayashi S, Tanemura M, et al. Advantage of autologous blood transfusion in surgery for hepatocellular carcinoma. World J Gastroenterol. 2011;17:3709–15.CrossRefPubMedPubMedCentral

29.

Blumberg N, Heal JM. Effects of transfusion on immune function. Cancer recurrence and infection. Arch Pathol Lab Med. 1994;118:371–9.PubMed

30.

Tomimaru Y, Eguchi H, Wada H, Hama N, Kawamoto K, Kobayashi S, et al. Predicting the necessity of autologous blood collection and storage before surgery for hepatocellular carcinoma. J Surg Oncol. 2013;108:486–91.CrossRefPubMed

Titel: Perioperative allogenic blood transfusion is a poor prognostic factor after hepatocellular carcinoma surgery: a multi-center analysis
verfasst von: Hiroshi Wada
Hidetoshi Eguchi
Hiroaki Nagano
Shoji Kubo
Takuya Nakai
Masaki Kaibori
Michihiro Hayashi
Shigekazu Takemura
Shogo Tanaka
Yasuyuki Nakata
Kosuke Matsui
Morihiko Ishizaki
Fumitoshi Hirokawa
Koji Komeda
Kazuhisa Uchiyama
Masanori Kon
Yuichiro Doki
Masaki Mori
Publikationsdatum: 08.06.2017
Verlag: Springer Japan
Erschienen in: Surgery Today / Ausgabe 1/2018
Print ISSN: 0941-1291
Elektronische ISSN: 1436-2813
DOI: https://doi.org/10.1007/s00595-017-1553-3

Leitlinien kompakt für die Allgemeinmedizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Facharzt-Training Allgemeinmedizin

Die ideale Vorbereitung zur anstehenden Prüfung mit den ersten 24 von 100 klinischen Fallbeispielen verschiedener Themenfelder

Mehr erfahren

Neu im Fachgebiet Allgemeinmedizin

19.04.2024 | EAU 2024 | Kongressbericht | Nachrichten

Update Allgemeinmedizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

Perioperative allogenic blood transfusion is a poor prognostic factor after hepatocellular carcinoma surgery: a multi-center analysis

Abstract

Purpose

Methods

Results

Conclusions

Leitlinien kompakt für die Allgemeinmedizin

Facharzt-Training Allgemeinmedizin

Neu im Fachgebiet Allgemeinmedizin

Prostatakarzinom: EU initiiert neues Screeningkonzept

Antihypertensiva schützen auch alte Menschen noch vor Demenz

Denken Sie bei starker Blutung auch an die Hemmkörper-Hämophilie

Delir kann Demenz begünstigen

Update Allgemeinmedizin

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

Abstract

Purpose

Methods

Results

Conclusions

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 1/2018

Treatment of lung adenocarcinoma by molecular-targeted therapy and immunotherapy

Expression of podoplanin in stromal fibroblasts plays a pivotal role in the prognosis of patients with pancreatic cancer

Pelvic inlet shape measured by three-dimensional pelvimetry is a predictor of the operative time in the anterior resection of rectal cancer

The efficacy of active drainage for preventing postoperative organ/space surgical site infections in patients with Crohn’s disease

One-day nasogastric tube decompression after distal gastrectomy: a prospective randomized study

Sentinel node biopsy for axillary management after neoadjuvant therapy for breast cancer: a single-center retrospective analysis with long follow-up

Leitlinien kompakt für die Allgemeinmedizin

Facharzt-Training Allgemeinmedizin

Neu im Fachgebiet Allgemeinmedizin

Prostatakarzinom: EU initiiert neues Screeningkonzept

Antihypertensiva schützen auch alte Menschen noch vor Demenz

Denken Sie bei starker Blutung auch an die Hemmkörper-Hämophilie

Delir kann Demenz begünstigen

Update Allgemeinmedizin